In this short blog post we draw attention to schistosomiasis and its links to premature birth, in recognition of World Prematurity Day.

Researchers at Brown University in the United States are looking at schistosomiasis and its effects on pregnant women in Leyte, a community in the Philippines. As a quick reminder for those who have not been following our growing interest in this insidious fluke, schistosomiasis is a water-borne parasite that wreaks havoc on internal organs, depending upon its strain.

Schisto-h affects the reproductive organs, while schisto-j affects the liver and is perhaps the most insidious. Though the effects of schistosomiasis have been studied for years, intense examination of its health effects on mother and fetus during pregnancy have somehow been neglected in much research until recently.

Friedman and Kurtis and their team are finding a link between schisto-j, placental inflammation and adverse birth outcomes, including prematurity in the population in Leyte, Philippines. Mothers who have schistosomiasis-j have higher levels of endotoxemia (1.3 times in maternal blood, 2.4 times higher in the placenta). Endotoxins are in turn, associated with prematurity. The Brown team has found that in pregnancy, schisto-j eggs also have proinflammatory response, also associated with prematurity and other adverse pregnancy events including intrauterine growth restriction and low birthweight.

Put in layman's terms, the schistosomiasis eggs cause a chronic infection and a long-term inflammatory response which is linked to problems in the placenta as well as in the maternal bloodstream.

But how big a problem is it potentially? Schistosomiasis affects some 200 million people worlwide, 40 million women of reproductive age. Schisto-j is endemic in countries with huge populations: China, The Philippines and Indonesia. Suffice it to say, that the problem is large and further exploration of the troublesome fluke in all its forms is important for women's health and for the prevention of prematurity.

 

Leave a comment

Comments will be approved before showing up.


Also in The Maternova Blog

Benefits of intravenous iron to treat anemia in pregnancy
Benefits of intravenous iron to treat anemia in pregnancy

March 19, 2024 5 min read

Read More
A Point of Care Bilirubinometer Using Blood: BiliDx
A Point of Care Bilirubinometer Using Blood: BiliDx

January 16, 2024 2 min read

The BiliDx is a novel system for diagnosing jaundice.  The device uniquely meets the Target Product Profile (TPP) developed as part of the NEST 360 initiative in that it allows blood-based testing at the bedside.   This initiative is part of an emerging global consensus in the Every Newborn Action Plan that countries need functional WHO level-2 inpatient units to care for "small and sick newborns." 
Read More
NASG as a life-saving medical device to stabilize women with postpartum hemorrhage
Clinical Indications for Applying (and Removing) the NASG: Rule of 20

January 15, 2024 2 min read

The garment must be removed upon reaching hemodynamic stability for at least two hours, where it is evident:

  • Blood loss less than 50 mL/hour
  • Pulse less than 100 beats per minute
Read More